Palatin Technologies (OTCMKTS:PTNT) Shares Cross Above 200-Day Moving Average – Time to Sell?

Palatin Technologies, Inc. (OTCMKTS:PTNT) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $9.99 and traded as high as $26.97. Palatin Technologies shares last traded at $26.44, with a volume of 206 shares trading hands.

Palatin Technologies Stock Up 2.3%

The stock has a market capitalization of $25.99 million, a PE ratio of -17.23 and a beta of 0.75. The stock’s 50 day moving average price is $18.19 and its 200-day moving average price is $10.28.

About Palatin Technologies

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy.